"The FDA Decision to approve Truvada* by 19 votes against 3 in the prevention of HIV transmission on May 11 is irresponsible and against Global Public Health Interests," declares Doctor

A drug that has been shown to prevent HIV infection in a significant number of cases must be combined with behavioral approaches if the U.S. health care establishment is to succeed in reducing the spread of the virus.

A panel of health experts have backed a drug to prevent HIV infection in healthy people for the first time.

UC San Diego (UCSD) is among three teams of investigators undertaking a four-year study testing an HIV prevention pill among people at high risk for the condition, reports Janet Lavelle for UT San Diego.

VOICE, an HIV prevention trial that has been evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women – daily use of one of two different ARV tablets or of a vaginal gel – will be dropping the vaginal gel from the study.